Long-Term Administration of Second-Line Chemotherapy with S-1 and Gemcitabine for Platinum-Resistant Non-small Cell Lung Cancer: A Phase II Study

Standard second-line chemotherapies for non-small cell lung cancer (NSCLC) have been established but have limited clinical relevance. S-1 is a recently developed agent with potential activity against NSCLC. Patients with confirmed NSCLC recurrence after previous single- or two-regimen chemotherapy w...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of thoracic oncology 2011-01, Vol.6 (1), p.156-160
Hauptverfasser:	Takiguchi, Yuichi, Seto, Takashi, Ichinose, Yukito, Nogami, Naoyuki, Shinkai, Tetsu, Okamoto, Hiroaki, Minato, Koichi, Seki, Nobuhiko, Eguchi, Kenji, Kishi, Kazuma, Nishikawa, Masanori, Watanabe, Koshiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - pathology Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carcinoma, Large Cell - drug therapy Carcinoma, Large Cell - pathology Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - pathology Deoxycytidine - administration & dosage Deoxycytidine - analogs & derivatives Drug Combinations Drug Resistance, Neoplasm - drug effects Female Gemcitabine Humans Lung Neoplasms - drug therapy Lung Neoplasms - pathology Maintenance Male Middle Aged Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - pathology Neoplasm Staging Non-small cell lung cancer Oxonic Acid - administration & dosage Platinum - adverse effects S-1 Salvage Therapy Second-line therapy Survival Rate Tegafur - administration & dosage Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!